Filing Details
- Accession Number:
- 0001209191-15-061972
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-21 20:47:53
- Reporting Period:
- 2015-07-20
- Filing Date:
- 2015-07-21
- Accepted Time:
- 2015-07-21 20:47:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1505512 | Regulus Therapeutics Inc. | RGLS | Pharmaceutical Preparations (2834) | 264738379 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1205903 | H William Rastetter | C/O Regulus Therapeutics Inc. 3545 John Hopkins Court, Suite 210 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-07-20 | 38,765 | $10.13 | 38,765 | No | 4 | P | Indirect | William H. Rastetter TTEE Investment 2002 Trust Boards U/A dated 11/11/2002 |
| Common Stock | Acquisiton | 2015-07-21 | 61,235 | $10.19 | 100,000 | No | 4 | P | Indirect | William H. Rastetter TTEE Investment 2002 Trust Boards U/A dated 11/11/2002 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | William H. Rastetter TTEE Investment 2002 Trust Boards U/A dated 11/11/2002 |
| No | 4 | P | Indirect | William H. Rastetter TTEE Investment 2002 Trust Boards U/A dated 11/11/2002 |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.10 to $10.15 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.05 to $10.25 inclusive. The reporting person undertakes to provide to RGLS, any security holder of RGLS, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Billionaire Hedge Funds
